Intera 3000, the Only FDA-Approved Implantable Pump for HAI Therapy, Showcased at ASCO Gastrointestinal Cancer Symposium 2023
BOSTON--(BUSINESS WIRE)--Intera Oncology® Inc., the manufacturer of the only FDA-approved implantable pump used for hepatic artery infusion (HAI) therapy, will showcase its Intera 3000 HAI Pump at the 2023 ASCO Gastrointestinal Cancer Symposium, taking place at the Moscone West in San Francisco, Calif. from January 19 to 20, 2023. HAI...
